Patients With Pharmaceutical Record Clinical Trial
— MATRIX-DPRSOfficial title:
Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System
| Verified date | March 2017 |
| Source | Centre Hospitalier Universitaire de Nice |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The aim of MATRIX-DPRS is to assess the clinical and organizational impacts of the use of the medication record, opened, filled and managed by pharmacists (from private office and hospital units) by hospital physicians in private and public healthcare establishments (volunteers), for three clinical contexts: anaesthesiology visit before surgery, medications abuse and emergency hospitalization, medications and elderly hospitalisations.
| Status | Completed |
| Enrollment | 511 |
| Est. completion date | June 30, 2016 |
| Est. primary completion date | June 30, 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: Concerning Anesthesia department: - Patients in pre-anesthesia consultation for scheduled intervention. Concerning Emergencies department: - Patients admitted for fainting fit Regarding patients hospitalized in geriatrics: - Patients admitted to geriatrics Exclusion Criteria: - Minors - Patients without administrative or judicial freedom if the authorization of the legal representative can not be collected. |
| Country | Name | City | State |
|---|---|---|---|
| France | CHU de Nice | Nice |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Nice |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Modification of the medical prescription linked to the use of the pharmaceutical record | The primary outcome measure is to evaluate the impact of the use of the pharmaceutical record on th medical prescription. The doctor writes a first medical prescription without using the pharmaceutical record and a second with the pharmaceutical record.The changes are analyzed. | 3 months |